Today: 15 May 2026
Browse Category

NASDAQ:GCTS 15 May 2026

TD Securities Filing Throws Spotlight on GCT Semiconductor (GCTS), Raises Flags About 5G Chip Scale-Up and Liquidity

TD Securities Filing Throws Spotlight on GCT Semiconductor (GCTS), Raises Flags About 5G Chip Scale-Up and Liquidity

TD Securities (USA) LLC disclosed a 4.6% beneficial ownership in GCT Semiconductor Holding, Inc., mostly via warrants exercisable at $11.50 a share, far above Friday’s $1.83 stock price. GCT reported first-quarter revenue of $1.92 million and a net loss of $9.86 million, with 5G chipset deliveries rising 58% to 3,000 units.
15 May 2026
··

Stock Market Today

  • Kraken Parent Payward Lays off 150 Employees Ahead of IPO
    May 15, 2026, 5:34 PM EDT. Kraken's parent company, Payward, is laying off approximately 150 employees, about 5% of its 3,000-strong workforce, as it prepares for an anticipated initial public offering (IPO). The layoffs, described as an optimization exercise, aim to present a leaner, more profitable company to potential investors. Payward had confidentially filed an S-1 registration with the SEC in November but paused IPO plans due to challenging market conditions. The company now plans to revive the process when conditions improve. Concurrently, Payward is expanding strategic collaborations, notably with Franklin Templeton, to develop blockchain-based investment products, and has applied for a national trust company charter with the Office of the Comptroller of the Currency.

Latest articles

Tonix Pharmaceuticals Stock Jumps as Lyme Disease Antibody Data Put 2027 Trial in Focus

Tonix Pharmaceuticals Stock Jumps as Lyme Disease Antibody Data Put 2027 Trial in Focus

15 May 2026
Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
AXT Stock’s AI Rally Hits Governance Snag as Annual Meeting Is Pushed to June

AXT Stock’s AI Rally Hits Governance Snag as Annual Meeting Is Pushed to June

15 May 2026
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized common shares to 120 million from 70 million. Shares closed at $123.78, up 7.65%, after a volatile session. China’s export controls on indium phosphide remain a key risk for AXT’s business.
Hyperscale Data Climbs on $5 Million Tender Offer; Spotlight Turns to 10-Q

Hyperscale Data Climbs on $5 Million Tender Offer; Spotlight Turns to 10-Q

15 May 2026
Hyperscale Data plans a tender offer to buy up to $5 million of Class A shares at $0.21 each, above the last GPUS trade at $0.146. The company reported a preliminary first-quarter net loss of about $30 million on revenue of $44 million and filed a late notice for its Form 10-Q. The offer is pending board and regulatory approval.
Go toTop